AMBER PECK: Open Payments
NPI 1013614767 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$901 in 46 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $181 · 2025 $901
Food & beverage: $901
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $185 |
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| GlaxoSmithKline, LLC. | 6 | $122 |
| PFIZER INC. | 5 | $96 |
| Lilly USA, LLC | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 4 | $58 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Abbott Laboratories | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
Products named: TRELEGY ELLIPTA, Ozempic, AIRSUPRA, JARDIANCE, VOQUEZNA, Rybelsus, BREZTRI, ELIQUIS.
Industry payments across MD — which companies pay providers there.
